Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Colorcon
Argus Health
Cantor Fitzgerald
Dow
Cipla
Accenture
Boehringer Ingelheim
Medtronic

Generated: April 25, 2018

DrugPatentWatch Database Preview

IMAGENT Drug Profile

« Back to Dashboard

When do Imagent patents expire, and what generic alternatives are available?

Imagent is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs.

The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.
Summary for IMAGENT
Drug patent expirations by year for IMAGENT

US Patents and Regulatory Information for IMAGENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alliance Pharm IMAGENT perflubron LIQUID;ORAL 020091-001 Aug 13, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for IMAGENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Federal Trade Commission
Express Scripts
Colorcon
McKinsey
Argus Health
Medtronic
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.